Trump Administration’s Mixed Messages on Health Policies
The Trump administration has claimed several successes under its “Make America Healthy Again” initiative. Notable actions include the removal of harmful fluoride medicines for children, the cancellation of a contract for mRNA vaccine development, and efforts to eliminate dangerous synthetic dyes and additives from food.
However, some supporters of the MAHA movement were taken aback this week by President Trump’s push for increased production of the controversial herbicide glyphosate. An executive order he signed stated that glyphosate-based herbicides are crucial to the nation’s agricultural productivity and rural economy. It indicated that limiting access could lead to economic losses for producers and fail to meet rising food demands.
“The chemical lobby controls Washington,” some critics argue, as President Trump described glyphosate production as vital to both economy and national security, invoking the Defense Production Act. He directed Secretary of Agriculture Brooke Rollins to ensure a steady supply of glyphosate herbicides, even granting legal protection to manufacturers involved.
Registered in the U.S. since 1974, glyphosate is among the most widely used pesticides. The U.S. Environmental Protection Agency has expressed that when used as directed, glyphosate poses “no risk of concern to human health” and is “unlikely to be a human carcinogen.”
Despite these assurances, skepticism about glyphosate’s safety persists. The International Agency for Research on Cancer has classified it as “probably carcinogenic to humans.” A report from Trump’s MAHA committee noted various health risks associated with glyphosate exposure, including cancer and metabolic disorders.
A 2023 study suggested that exposure during childhood might increase the likelihood of liver and heart issues in adulthood. Additionally, a 2019 study linked prenatal glyphosate exposure to a heightened risk of autism spectrum disorder.
Research published last year indicated that even low doses of glyphosate could lead to cancer in rats. These findings align with epidemiological evidence showing increased cancer rates in humans exposed to glyphosate products.
Zen Honeycutt, an activist with MAHA, expressed concern that the executive order could result in irreversible damage. She stated that it breaks Trump’s prior commitments regarding pesticide regulation and threatens the health of families and farmland for generations.
Toxicologist Alexandra Muñoz criticized the administration’s approval of glyphosate’s production, calling it “outrageous and unacceptable.” Vani Hari, founder of Food Babe, reflected on a troubling trend where every president has increased glyphosate usage, attributing control to the chemical lobby.
As a result of this executive order, Bayer, the company behind the glyphosate product Roundup, announced a proposed $7.25 billion settlement over numerous lawsuits claiming the product is linked to cancer, although they maintain no admission of liability.
Health and Human Services Secretary Robert F. Kennedy Jr. defended the glyphosate initiative, emphasizing the need for national security and food supply stability. He previously condemned glyphosate but now focuses on its production’s implications for security amidst global tensions.
